Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeted Diazotransfer Reagents Enable Selective Modification of Proteins with Azides.

Jonas Lohse1, Lotteke J Y M Swier2, Ruben C Oudshoorn2

  • 1Chemical Biology II, Stratingh Institute for Chemistry, University of Groningen , Nijenborgh 7, 9747 AG Groningen, The Netherlands.

Bioconjugate Chemistry
|March 31, 2017
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AURORA A interacts with DICER and SETD2 to promote S-phase progression.

EMBO reports·2026
Same author

Proteome profiling reveals NQO2 activity contributing to proteasome inhibitor resistance in multiple myeloma cell lines.

Molecular & cellular proteomics : MCP·2026
Same author

Pathogenesis of diffuse large B cell lymphoma proteogenotypes.

Cancer cell·2026
Same author

Multi-omics of barley Fusarium Head Blight converge on pathogen-triggered biosynthesis of aromatic amino acid derived chemical defense compounds.

Stress biology·2026
Same author

INAAC: An affinity chromatography strategy enabling characterization and quantification of influenza neuraminidase antigens in vaccines.

The Journal of biological chemistry·2026
Same author

Rapid photo-crosslinking in living cells reveals protein-nucleic acid dynamics on a timescale of minutes.

Nucleic acids research·2026

Researchers developed a new biotin-tethered reagent, DtBio, to selectively add azides to specific amino groups in endogenous proteins. This method enables precise bioorthogonal modification for applications like target identification and protein functionalization.

Area of Science:

  • Chemical Biology
  • Bioconjugation Chemistry
  • Molecular Biology

Background:

  • Azides are crucial for bioorthogonal chemistry, enabling targeted modifications in biological systems.
  • Existing methods for azide introduction primarily target recombinant proteins, leaving a gap for endogenous protein modification.
  • Selective functionalization of endogenous proteins is essential for advanced applications like target identification and drug delivery.

Purpose of the Study:

  • To develop a novel reagent for the direct and selective introduction of azido groups into endogenous proteins.
  • To demonstrate the efficacy of the new reagent in modifying specific amino groups within proteins.
  • To explore the potential applications of this selective protein modification technique.

Main Methods:

Related Experiment Videos

  • Development of a biotin-tethered diazotransfer reagent (DtBio).
  • Application of DtBio to model proteins (streptavidin, avidin) and a cell surface membrane protein (BioY).
  • Analysis of azide modification sites using biochemical and biophysical techniques.

    • Main Results:

    • DtBio selectively converted amino groups near the binding pocket of streptavidin and avidin to azides.
    • The reagent demonstrated high selectivity, leaving other amino groups on streptavidin unmodified.
    • Successful modification of the membrane protein BioY on the cell surface was achieved.
    • The biotin tag facilitated potential isolation and purification of modified proteins.

    Conclusions:

    • DtBio represents the first reagent capable of direct, selective azidation of endogenous proteins.
    • This novel class of reagents opens new avenues for target identification and bioorthogonal protein functionalization.
    • The selective modification capability holds promise for developing precisely engineered protein conjugates and therapeutic agents.